Citi and others are bullish on biotech, medtech and more
2023 wasn't a very good 12 months for the health-care sector, but some investors expect it to make a comeback ...
2023 wasn't a very good 12 months for the health-care sector, but some investors expect it to make a comeback ...
Many biotech stocks struggled in 2023 despite a strong yr for U.S. drug approvals. As these latest therapies begin treating ...
Test tubes are seen in front of a displayed AbbVie logo on this illustration taken on May 21, 2021.Dado Ruvic ...
Regeneron Pharmaceuticals (REGN) rose Monday after the Food and Drug Administration approved a higher-dose formulation of Eylea, the corporate's macular ...
Shares of Krystal Biotech can rally nearly 60% as use of its gene therapy to treat cases of herpes simplex ...
On Dec. 30, leaders of the House and Senate Armed Services committees announced the choice of former Google CEO Eric ...
Investors on the lookout for cover this 12 months would have done well in the event that they sought a ...
U.S. biotech stocks have been on the up recently. The S & P Biotechnology Select Industry Index is up greater ...
[mailpoet_form id=”1″]
© 2022. All Right Reserved By Inbvnews.com